You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Correction: Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study

Article metrics

Article menu

See original article:

Download PDFPDF

XML
Correction
Correction: Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study

 

Online download statistics by month:

Online download statistics by month: July 2020 to June 2025

AbstractFullPdf
Jul 202005820
Aug 20200308
Sep 20200379
Oct 20200147
Nov 20200157
Dec 20200127
Jan 20210266
Feb 20210136
Mar 20210159
Apr 20210155
May 20210158
Jun 20210249
Jul 20210126
Aug 2021094
Sep 2021098
Oct 202101118
Nov 202101611
Dec 20210207
Jan 2022093
Feb 202201711
Mar 20220169
Apr 20220115
May 202202513
Jun 20220216
Jul 2022093
Aug 20220243
Sep 20220229
Oct 202201916
Nov 20220173
Dec 2022073
Jan 2023067
Feb 20230291
Mar 202301310
Apr 2023053
May 20230610
Jun 2023085
Jul 20230127
Aug 202301221
Sep 2023091
Oct 20230125
Nov 202302110
Dec 20230232
Jan 2024092
Feb 20240131
Mar 202401344
Apr 2024072
May 20240102
Jun 20240163
Jul 20240155
Aug 20240135
Sep 202401211
Oct 20240113
Nov 20240153
Dec 20240195
Jan 20250121
Feb 20250182
Mar 20250154
Apr 20250286
May 2025092
Jun 20250135
Total0952427